The growth of personalized medicine in oncology continues to fuel a shift from traditional chemotherapies to immunotherapy. Currently, there are more than 30 immunotherapies approved for use in the United States, with more than 2,300 immunotherapy clinical trials listed on ClinicalTrials.gov.
Thomas D. Brown was named chief medical officer at Syapse.
Anna D. BarkerHoward FingertAndrea Hayes-JordanSusan T. VadaparampilThe White House has named the following individuals to the National Cancer Advisory Board:
Virginia Tech has developed a strategy to increase cooperation and connections among its more than 30 cancer research teams, help recruit additional cancer researchers, provide access to state-of-the-art shared research resources, foster relationships with institutions and agencies recognized as world leaders in cancer treatment and research, and enhance the already substantial cancer research funding at the university.
The Cancer Research Institute has presented awards to seven scientists:
The Dr. Josef Steiner Cancer Research Prize 2019, goes to Serena Nik-Zainal from the Department of Medical Genetics, University of Cambridge.
Vadim Backman was named associate director for Research Technology and Infrastructure at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University.
City of Hope announced a partnership to provide a range of enhanced cancer support services to Amazon employees in the U.S.—including a dedicated phone line staffed by oncology nurses, specialized support for complex cancers and diagnosis and treatment plan review.
NCI has awarded a four-year, more than $1.87 million grant to University of North Carolina Lineberger Comprehensive Cancer Center researchers to study the impact of implementing financial navigation services at five rural cancer centers in North Carolina to help patients cope with the financial burden, or financial toxicity, related to cancer care.
The American Cancer Society, Union for International Cancer Control and International Agency for Research on Cancer have published The Cancer Atlas, 3rd edition, an overview of cancer around the globe.
